Metastatic Gastro-intestinal Neuroendocrine Tumors: A Case Report of Real Life Management Challenges and Success

ISSN: 1875-6301 (Online)
ISSN: 1573-3947 (Print)

Volume 13, 2 Issues, 2017

Download PDF Flyer

Current Cancer Therapy Reviews

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Kurt S. Zaenker
Institute of Immunology and Experimental Oncology University Witten/Herdecke
Stockumerstraße 10, 58448 Witten

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Metastatic Gastro-intestinal Neuroendocrine Tumors: A Case Report of Real Life Management Challenges and Success

Current Cancer Therapy Reviews, 9(3): 220-225.

Author(s): Jamal Zekri and Zahid Amin Khan.

Affiliation: Department of Oncology, King Faisal Specialist Hospital & Research Center (Jeddah, Saudi Arabia). Al Faisal University, Saudi Arabia.


Introduction: Until recently, there have been limited options for treatment of metastatic neuro endocrine tumors (NETs). Real life experience with newly developed targeted therapies for this condition is limited outside large referral centers.

Case: Here we describe a 43 year old patient with metastatic NET of intestinal origin. The management of this patient illustrates a number of real life practical issues including effect of treatment interruption, secondary resistance to somatostatin analogues, availability and toxicity of new targeted agents, multiple lines of sequential treatment and local availability of specific investigations. This patient is enjoying a long progression free survival (29+ months) on a combination of Everolimus and Octreotide-LAR with a survival of 43+ months from diagnosis of metastatic disease.

Conclusion: Patient with metastatic NETs can benefit from newly developed targeted therapies. However, they are best managed by multi-disciplinary teams in referral centers to guarantee adequate experience and specialist resources.


Neuroendocrine, targeted therapy, Octreotide-LAR, Everolimus, Sunitinib, multi-disciplinary.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 9
Issue Number: 3
First Page: 220
Last Page: 225
Page Count: 6
DOI: 10.2174/1573394709666131108210254
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science